Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000467524 | SCV000558198 | benign | Familial focal epilepsy with variable foci | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311789 | SCV000846391 | benign | Inborn genetic diseases | 2016-02-24 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001683513 | SCV001899154 | benign | not provided | 2018-07-27 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001683513 | SCV005275482 | benign | not provided | criteria provided, single submitter | not provided | ||
Athena Diagnostics | RCV004999496 | SCV005620866 | benign | not specified | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV005365339 | SCV005912817 | benign | Focal epilepsy | 2023-04-03 | criteria provided, single submitter | research | |
Bioinformatics Core, |
RCV000656071 | SCV000588347 | pathogenic | Self-limited epilepsy with centrotemporal spikes | 2017-01-01 | no assertion criteria provided | case-control | CAADphred>15 |